Our research explores new innovative ways to transform therapeutics, implants, drug delivery vehicles, imaging contrast agents, surgical tools and biosensors. We collaborate with researchers and clinicians, within and outside of the university, to develop new technologies that can be translated for improving outcomes in human health. 

Our focus areas include:

• biological and synthetic biomaterials
• biomaterials-facilitated tissue cultures as disease models and for accelerating drug discovery
• biomaterial diagnosis while simultaneously delivering therapeutic treatment of cancers through radiotracers

All of which aim to improve the immune system, augment tissue repair and combat infections.

Biomaterials innovation and translation is a profoundly interdisciplinary field, involving collaborations between researchers in materials science, engineering, biology, drug delivery, regenerative medicine, tissue engineering and regulatory affairs. Researchers and engineers are working to design materials with specific properties, such as biocompatibility, mechanical strength and degradation rate, to meet the needs of different medical applications. 

The field is driven by a need for new materials that are safe, effective and compatible with the human body and has promising research in regenerating damaged tissue and creating new organs.